ICS 2016 Scientific Open Discussion Session S7

Open Discussion ePosters

Scientific Open Discussion Session S7

Speakers
	Wednesday 14th September 2016
	12:00 - 13:00
	ePoster Area
M Magdy M Hassouna ICS Chair R Roman Zachoval ICS Chair R Ryuji Sakakibara ICS Chair S Sophie G Fletcher ICS Chair A Alex Digesu ICS Chair W Waleed M Altaweel ICS Chair J Jerzy B Gajewski ICS Chair C Charalampos Konstantinidis ICS Chair

Station	Topics	Chair	Abstracts
ePoster Station 1	Male LUTS	Magdy Hassouna	67 - 77
ePoster Station 2	Male LUTS	Roman Zachoval	78 - 89
ePoster Station 3	Male LUTS	Ryuji Sakakibara	88 - 99
ePoster Station 4	Male LUTS / OAB	Sophie Fletcher	100 - 111
ePoster Station 5	OAB	Alex Digesu	110 - 121
ePoster Station 6	OAB	Waleed Altaweel	122 - 132
ePoster Station 7	OAB / Urodynamics	Jerzy B Gajewski	133 - 148
ePoster Station 8	Urodynamics	Charalampos Konstantinidis	138 - 154

Session Schedule

12:05

#67 THE EFFICACY AND SAFETY OF CONTACT LASER VAPORIZATION OF THE PROSTATE (CVP) IN TREATING BENIGN PROSTATE HYPERPLASIA

Presenter: Hideyo Miyazaki

Miyazaki H¹, Hirano Y², Kato S³, Ioritani N⁴, Ichikawa T⁵, Takamoto H⁵, Homma Y¹
1. Department of Urology, University of Tokyo Hospital, 2. The Fraternity Memorial Hospital, 3. Kato Urological Clinic, 4. JCHO Sendai Hospital, 5. Kurashiki Medical Center
Male, Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Surgery
ePoster Station 1

12:10

#68 Post-bulbar urethroplasty peri-catheter urethrogram (PUG), is it really required?

Presenter: Christopher Thompson

Thompson C¹, Shahzad K², El-Mokadem I¹, Denholm L¹, Hillen M¹, Alhasso A¹, Keanie J², Stewart L¹
1. Urology Department, Western General Hospital, Edinburgh, 2. Radiology Department, Western General Hospital, Edinburgh
Grafts: Biological, Surgery, Imaging, Male, Retrospective Study
ePoster Station 1

12:15

#69 Comprehensive review of histopathological findings of ketamine related cystitis and correlation with clinical parameters

Presenter: Jia-Fong Jhang

Jhang J¹, Wu S¹, Ong H¹, Kuo H¹
1. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Infection, other, Pathophysiology, Painful Bladder Syndrome/Interstitial Cystitis (IC)
ePoster Station 1

12:20

#70 Factors Affecting Recurrence in Patients with Urethral Stricture Underwent Direct Vision Internal Urethrotomy

Presenter: Fuat Kizilay

Kizilay F¹, Akincioglu E¹, Eskidemir Ü¹, Simsir A¹, Ozyurt M C¹
1. Ege University
Bladder Outlet Obstruction , Male, Retrospective Study, Surgery
ePoster Station 1

12:25

#71 Changes of the bladder function following radical prostatectomy: Comparisons between robot-assisted laparoscopic and open retropubic procedures from a multicenter database

Presenter: Seong Jin Jeong

Jeong S J¹, Lee D H¹, Jeong Y S¹, Lee J K¹, Lee S M¹, Choo M S², Cho S Y³, Kwak C⁴, Oh S⁴
1. Department of Urology, Seoul National University Bundang Hospital, 2. Department of Urology, Hallym University Dongtan Sacred Heart Hospital, 3. Department of Urology, SMG-SNU Boramae Medical Center, 4. Department of Urology, Seoul National University Hospital
Detrusor Overactivity, Male, Surgery, Urodynamics Techniques, Underactive Bladder
ePoster Station 1

12:30

#72 Long-term Functional Outcomes and Durability of Artificial Urinary Sphincter (AMS 800™) Implantation in Men with Stress Urinary Incontinence

Presenter: Kwang Jin Ko

Ko K J¹, Suh Y S¹, Chung J Y², Jeong J Y³, Lee K¹
1. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, 2. Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea, 3. Center for Health Promotion, Samsung Medical Center, Seoul, Korea
Male, Incontinence, Stress Urinary Incontinence
ePoster Station 1

12:35

#73 Incontinence after Laparoscopic Radical Prostatectomy-- the Predictors of Early Recovery and Videourodynamic Changes

Presenter: Yu-Hua Lin

Lin Y¹, Huang H¹, Ku C¹, Jiang Y², Lin V C³, Tsai Y⁴, Kuo H²
1. Cardinal Tien Hospital, 2. Buddhist Tzu-Chi General Hospital, 3. E-Da Hospital, 4. Taipei Tzu Chi General Hospital
Incontinence, Male, Retrospective Study, Surgery, Urodynamics Techniques
ePoster Station 1

12:40

#74 Factors associated with early recovery of continence after robot-assisted radical prostatectomy

Presenter: Yuta Yamada

Yamada Y¹, Fujimura T¹, Sugihara T¹, Miyazaki H¹, Nakagawa T¹, Fukuhara H¹, Igawa Y¹, Homma Y¹
1. The University of Tokyo Hospital
Male, Incontinence, Surgery
ePoster Station 1

12:45

#75 Qualitative development of a new patient reported outcome measure for underactive bladder

Presenter: Nikki Cotterill

Uren A¹, Cotterill N¹, Harding C², Hillary C³, Chapple C³, Klaver M⁴, Bongaerts D⁴, Hakimi Z⁴, Abrams P¹
1. Bristol Urological Institute, UK, 2. Freeman Hospital, Newcastle, 3. Royal Hallamshire Hospital, Sheffield, 4. Astellas Pharma B.V., Leiden, The Netherlands
Questionnaire, Underactive Bladder, Quality of Life (QoL)
ePoster Station 1

12:50

#76 The Korean clinical practice guideline for benign prostatic hyperplasia

Presenter: Jeong Kyun Yeo

Yeo J K¹, Choi H², Bae J H², Cho Y S³, Kim H J⁴
1. Dept. of Urology, Seoul Paik hospital, 2. Department of Urology, Korea University College of Medicine, 3. Department of Urology, Sungkyunkwan University College of Medicine, 4. Department of Urology, Dankook University College of Medicine
Benign Prostatic Hyperplasia (BPH), Male, Bladder Outlet Obstruction
ePoster Station 1

12:55

#77 Evolution of the FlowSecure Artificial Urinary Sphincter.

Presenter: Ammar Alhasso

Dooher M¹, Stewart L¹, Alhasso A¹
1. Western General Hospital, Edinburgh, Scotland
Incontinence, Stress Urinary Incontinence, Pad Test, Surgery, New Devices
ePoster Station 1

12:05

#78 Who are suitable for low-dose tamsulosin monotherapy as initial treatment strategy in male patients with lower urinary tract symptoms?

Presenter: Ji Sung Shim

Shim J S¹, Kim J Y¹, Pyun J H¹, Cho S¹, Kang S G¹, Kang S H¹, Cheon J¹, Kim J J¹, Lee J G¹
1. Department of Urology, Korea University College of Medicine
Male, Quality of Life (QoL), Questionnaire
ePoster Station 2

12:10

#79 Long-term outcome after implantation of the ATOMS continence device: 7 year multi-center data

Presenter: Alexander Friedl

Friedl A¹, Zachoval P², Mühlstädt S³, Giammò A⁴, Kivaranovic D⁵, Rom M⁶, Fornara P³, Brössner C¹
1. Hospital Göttlicher Heiland, Department of Urology, Vienna, Austria, 2. Thomayer Hospital, Department of Urology and 1st and 3rd Medical Faculty, Charles University, Prague, Czech Republic, 3. Klinik and Poliklinik of Urology and Kidney Transplantation, University Hospital, Martin-Luther-University, Halle-Wittenberg, Halle/Saale, Germany, 4. Neuro-Urology Department, CTO-Maria Adelaide Hospital, Turin, Italy, 5. Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University Vienna, Vienna, Austria, 6. Department of Urology, Medical University Vienna, Vienna, Austria
Male, Stress Urinary Incontinence, New Devices, Surgery, Quality of Life (QoL)
ePoster Station 2

12:15

#80 Urethroplasty for Urethral Stricture after Radial Forearm Flap Phalloplasty for Female to Male Gender Confirmation Surgery- A Case Series

Presenter: Nikita Abhyankar

Abhyankar N¹, Huang J¹, Schechter L¹, Kocjancic E¹
1. University of Illinois at Chicago
Anatomy, Fistulas, Male
ePoster Station 2

12:20

#81 Evaluation of incontinence after robot-assisted laparoscopic radical prostatectomy (RARP) : Using International Consultation on Incontinence Modular Questionnaire Short Form (ICIQ-SF) and number of the pad in Japanese patients.

Presenter: Kastuya Hikita

Hikita K¹, Honda M¹, Kawamoto B¹, Panagiota T¹, Morizane S¹, Muraoka K¹, Sejima T¹, Takenaka A¹
1. Division of Urology, Department of Urology, Tottori University Faculty of Medicine
Incontinence, Quality of Life (QoL), Questionnaire
ePoster Station 2

12:25

#82 Urinary incontinence after Holmium Laser Enucleation of the Prostate; Assessment of the predictors and time to continence recovery.

Presenter: Ahmed Elshal

Elshal A¹, Taha D¹, Eldemerdash Y¹, El-Assmy A¹, El-Nahas A¹
1. Manosura Urology and Nephrology center
Benign Prostatic Hyperplasia (BPH), Incontinence, Male
ePoster Station 2

12:30

#83 Integrated microRNA-mRNA profiling identifies molecular biomarkers in bladder outlet obstruction-induced lower urinary tract dysfunction

Presenter: Fiona Burkhard

Burkhard F¹, Hashemi Gheinani A¹, Monastyrskaia K¹
1. University Bern
Benign Prostatic Hyperplasia (BPH), Molecular Biology, Detrusor Hypocontractility, Detrusor Overactivity, Bladder Outlet Obstruction
ePoster Station 2

12:35

#84 The transitional period from OAB to UAB; decreased contractility and increased residual urine in a rat model of chronic ischemic bladder

Presenter: Norifumi Sawada

Sawada N¹, Kira S¹, Mitsui T¹, Takeda M¹
1. University of Yamanashi, Dept of Urology
Animal Study, Physiology, Underactive Bladder
ePoster Station 2

12:40

#85 Urethral pressure profile for the perioperative assessment of the patients undergoing Radical Prostatectomy

Presenter: Hoi-chu To

To H¹, Kam Y¹, Kan C¹, Ho L¹, Au W¹
1. Queen Elizabeth Hospital, Hong Kong
Incontinence, Male, Nursing, Rehabilitation, Urodynamics Techniques
ePoster Station 2

12:45

#86 Predictors of improvement in storage symptoms at 3-year after 120W GreenLight High Performance System laser for benign prostate hyperplasia

Presenter: Sung Yong Cho

Song W H¹, Jeon H J¹, Park J², Cho S Y², Cho M C², Jeong H², Son H², Bae J³
1. Seoul National University Hospital, 2. SMG-SNU Boramae Medical Center, 3. Dongguk Univeristy Ilsan Hospitall, Goyang, South Korea
Benign Prostatic Hyperplasia (BPH), Surgery, Urgency/Frequency
ePoster Station 2

12:50

#87 Outcome analysis of using antimuscarinics in BPH patients with storage symptoms prior to surgery – a nationwide population-based study

Presenter: Eric Yi-Hsiu Huang

Huang E Y¹, Chung H¹, Lin C¹, Fan Y¹, Peng R¹, Chang Y¹, Lin A T¹, Chen K¹
1. Taipei Veterans General Hospital
Benign Prostatic Hyperplasia (BPH), Detrusor Overactivity, Male
ePoster Station 2

12:55

#89 Lower urinary tract symptoms as adverse events of androgen axis blockade in prostate cancer patients: Data mining of the public version of the FDA adverse event reporting system

Presenter: Koji Yoshimura

Yoshimura K¹, Kadoyama K², Tamon A³, Okuno Y²
1. Shizuoka General Hospital, 2. Kyoto University Graduate School of Pharmaceutical Sciences, 3. Kyoto Constella Technologies
Hormone Therapy, Male, Urgency/Frequency
ePoster Station 2

12:05

#88 Risk factors for impaired functional outcome and postoperative incontinence in men with radical cystectomy and orthotopic ileal neobladder

Presenter: Markus Tobias Grabbert

Grabbert M T¹, Grimm T¹, Buchner A¹, Kretschmer A¹, Apfelbeck M¹, Schneevoigt B¹, Jokisch F¹, Schulz G¹, Stief C G¹, Karl A¹, Bauer R M¹
1. Department of Urology, Ludwig-Maximilians-University Munich (LMU)
Incontinence, Surgery, Male, Pathophysiology
ePoster Station 3

12:10

#90 Subgroup analyses of triple therapy with tamsulosin, dutasteride, and imidafenacin for benign prostatic hyperplasia patients with overactive bladder symptoms refractory to tamsulosin (24-week randomized comparative study: DIrecT Study)

Presenter: Tomonori Yamanishi

Yamanishi T¹, Asakura H², Seki N³, Tokunaga S⁴
1. Dokkyo Medical University, Continence Center, 2. Saitama Medical University Hospital, 3. Kyushu Central Hospital, 4. Medical Information Center, Kyushu University Hospital
Benign Prostatic Hyperplasia (BPH), Clinical Trial, Male, Overactive Bladder, Pharmacology
ePoster Station 3

12:15

#91 VALIDATION OF THE TOTO FLOWSKY UROFLOWMATRY DEVICE

Presenter: Woon Tsang

Tsang W¹, Liong Y V¹, Raman L¹, Wai Z M¹, Consigliere D¹, Chiong E¹
1. National University Hospital, Singapore
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Voiding Dysfunction , New Devices
ePoster Station 3

12:20

#92 DO PELVIC FLOOR MUSCLES STRENGTH AND URODYNAMIC PARAMETERS PREDICT EARLY INCONTINENCE OUTCOMES AFTER RADICAL RETROPUBIC PROSTATECTOMY?

Presenter: Flavio Trigo-Rocha

Magnabosco W¹, Laurienzo C¹, Jabur F¹, Gameiro M², Kawano P³, Yamamoto H³, Amaro J³, Trigo-Rocha F⁴
1. Hospital do Cancer de Barretos - SP - Brasil, 2. Physiotherapy Service - UNESP, 3. Medical School of Botucatu - UNESP, 4. Faculdade de Medicina da Universidade de São Paulo, Division of Urology, São Paulo, SP, Brazil
Incontinence, Male, Voiding Dysfunction
ePoster Station 3

12:25

#93 Study on the effects of alpha-1 blocker discontinuation in patients with LUTS/BPH receiving combination therapy of dutasteride and alpha-1 blocker.

Presenter: Masaki Watanabe

Watanabe M¹, Hashizume K¹, Wada N¹, Matsumoto S¹, Kakizaki H¹
1. Asahikawa medical university
Benign Prostatic Hyperplasia (BPH), Male, Overactive Bladder
ePoster Station 3

12:30

#94 AdVance XP male sling: 3-year follow up of a prospective multicenter study

Presenter: Markus Tobias Grabbert

Grabbert M T¹, Klehr B¹, Kretschmer A¹, Gozzi C², Rehder P³, May F⁴, Homberg R⁵, Gebhartl P⁶, Stief C G¹, Bauer R M¹
1. Department of Urology, Ludwig-Maximilians-University Munich (LMU), 2. Department of Urology, Marienklinik, Bolzano, 3. Department of Urology, University of Innsbruck, 4. Department of Urology, Dachau Hospital, 5. Department of Urology, St. Barbara Hospital Hamm, 6. Department of Urology, Voecklabrueck Hospital
Clinical Trial, Incontinence, Male, Stress Urinary Incontinence
ePoster Station 3

12:35

#95 Predicting Time to Recovery of Urinary Retention

Presenter: Jung Hoon Kim

Kim J H¹, Chang I H², Kim J W², Chi B H², Kim T H², Kim K D², Moon Y T², Myung S C²
1. Hanil geneal hospital, Seoul, South Korea, 2. Chung-Ang University Hospital, Seoul, South Korea
Conservative Treatment, Detrusor Hypocontractility, Voiding Dysfunction
ePoster Station 3

12:40

#96 Roles of urodynamics in the assessment of post radical prostatectomy incontinence: do findings change patient management?

Presenter: Janice Cheng

Cheng J¹, Patel A², Tse V¹, Chan L¹
1. Concord Repatriation General Hospital, Sydney, Australia, 2. City Hospitals Sunderland NHS Foundation Trust, UK
Incontinence, Male, Surgery, Detrusor Overactivity
ePoster Station 3

12:45

#97 Urinary Uric Acid Induces Prostatic Inflammation in a Rat

Presenter: Yasuhito Funahashi

Funahashi Y¹, Majima T¹, Matsukawa Y¹, Yamamoto T¹, Yoshida M², Gotoh M¹
1. Department of Urology, Nagoya University, 2. Department of Urology, National Center for Geriatrics and Gerontology
Animal Study, Basic Science, Male, Pathophysiology, Benign Prostatic Hyperplasia (BPH)
ePoster Station 3

12:50

#98 Which prostate is enucleated more efficiently during Holmium Laser Enucleation of the Prostate (HoLEP)?

Presenter: Tae Beom Kim

Kim T B¹, Kim K T¹, Oh J K¹, Kim K H¹, Jung H¹, Yoon S J¹
1. Department of Urology, Gachon University Gil Hospital
Benign Prostatic Hyperplasia (BPH), Surgery, Retrospective Study
ePoster Station 3

12:55

#99 Clinical and patient reported outcome for urethroplasty with lingual mucosa in anterior urethral strictures

Presenter: Elisabeth Spierings

Spierings E¹, Oude Elferink P², Taubert E³
1. Radboud University Medical Centre, 2. Canisius Wilhelmina Hospital, 3. Slingeland Hospital
Quality of Life (QoL), Retrospective Study, Questionnaire, Surgery, Voiding Dysfunction
ePoster Station 3

12:05

#100 Management of lower urinary tract symptoms related to benign prostatic hyperplasia: temporal trends of hospitalization rates over 5 years in a large Spanish men population

Presenter: Emilio Lopez Alcina

Lopez Alcina E¹, Navarro Perez J², Brotons Munto F³, Calabuig Perez J⁴
1. Hospital General Universitario de Valencia, 2. Hospital Clinico Universitario de Valencia, 3. Centro de Salud La Plana Castellon, 4. Conselleria de Sanitat Valencia
Benign Prostatic Hyperplasia (BPH), Male, Surgery, Retrospective Study
ePoster Station 4

12:10

#101 Urinary incontinence after anastmotic urethroplasty in adult males and potential treatment

Presenter: Bassem Wadie

Wadie B¹, Abed A¹, Othman Y¹, Shehab El Dein A¹
1. Urology and Nephrology Center
Incontinence, Male, New Devices
ePoster Station 4

12:15

#102 Influence of urethral kinking on OAB symptoms in patients with symptomatic anterior compartment prolapse

Presenter: Irene Diez-Itza

Diez-Itza I¹, Martinez-Martin A², Uranga S¹, Avila M¹, Lekuona A¹, Garcia-Hernandez J A²
1. Hospital Universitario Donostia, 2. Complejo Hospitalario Universitario Insular Materno Infantil
Overactive Bladder, Pathophysiology, Pelvic Organ Prolapse
ePoster Station 4

12:20

#103 Success of a repeated tined lead trial in a refractory OAB population

Presenter: Tomas Griebling

Noblett K¹, Mangel J², Comiter C³, Bird E⁴, Griebling T⁵, Sutherland S E⁶, Berg K⁷, Kan F⁷, Siegel S⁸
1. University of California, Riverside, 2. MetroHealth Medical Center, 3. Stanford University, 4. Scott and White Healthcare, 5. University of Kansas, Kansas City, 6. University of Washington, Seattle, 7. Medtronic, 8. Metro Urology
Clinical Trial, Incontinence, Neuromodulation
ePoster Station 4

12:25

#104 Impact of side effects on choice of anti-cholinergic medications for overactive bladder in an older population: a discrete choice experiment

Presenter: Candy Kumps

Kumps C¹, Decalf V¹, Benoit D², Huion A³, Denys M¹, De Witte N³, Everaert K¹
1. Ghent University Hospital, 2. Ghent University, 3. University College Ghent
Overactive Bladder, Quality of Life (QoL), Pharmacology, Questionnaire
ePoster Station 4

12:30

#105 The ROSETTA Urinary Marker Study

Presenter: Holly Richter

Richter H¹, Moalli P², Amundsen C³, Malykhina A⁴, Rogers R⁵, Myers D⁶, Paraiso M⁷, Albo M⁸, Nolen T⁹, Wallace D⁹, Meikle S¹⁰, Word A¹¹
1. University of Alabama at Birmingham, 2. University of Pittsburgh, 3. Duke University, 4. University of Colorado, Denver, 5. University of New Mexico, 6. Brown University, 7. Cleveland Clinic, 8. University of California, San Diego, 9. RTI International, 10. Eunice Kennedy Shriver National Institute of Child Health and Human Development, 11. University of Texas, Southwester
Neuromodulation, Overactive Bladder, Urgency Urinary Incontinence
ePoster Station 4

12:35

#106 Interim results from a pan-European non-interventional study assessing quality of life and persistence in overactive bladder patients prescribed mirabegron

Presenter: Moses Huang

Freeman R¹, Grill R², Kachlírová Z², Walters C³, Choudhury N³, Stari A³, Huang M³
1. Derriford Hospital, Plymouth, 2. Charles University, Prague, 3. Astellas Pharma Europe Ltd
Quality of Life (QoL), Questionnaire, Clinical Trial
ePoster Station 4

12:40

#107 Risk factors of overactive bladder and factors affecting the severity of overactive bladder symptoms in Korean women who use public health centers

Presenter: Eun-Hee Yoo

Yoo E¹, Pyeon S Y²
1. Kyung Hee University hospital at Gangdong, 2. Kyung Hee University Hospital at Gangdong
Overactive Bladder, Female, Questionnaire
ePoster Station 4

12:45

#108 Ketamine abuse and lower urinary tract symptoms: a survey from drug rehabilitation centers in Taiwan

Presenter: Ting Hui-Kung

Hui-Kung T¹, Chiao-Ching L¹, Seng-Tang W¹, Tai-Lung C¹, Guang-Huan S¹, Dah-Shyong Y¹, En M¹
1. Tri-Service General Hospital, National Defense Medical center
Urgency/Frequency, Pain, other, Voiding Dysfunction , Questionnaire
ePoster Station 4

12:50

#109 INTRAVESICAL BOTULINUM TOXIN-A INJECTIONS DECREASES URINARY ATP CONCENTRATIONS IN PATIENTS WITH OVERACTIVE BLADDER

Presenter: Miguel Silva-Ramos

Silva-Ramos M¹, Silva I², Reis D¹, Oliveira J C³, Correia-de-Sá P²
1. Department of Urology, Centro Hospitalar do Porto, 2. Department of Pharmacology and Neurobiology, Center for Drug Discovery and Innovative Medicines, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, 3. Department of Biochemistry, Centro Hospitalar do Porto
Overactive Bladder, Physiology, Prospective Study, Pathophysiology, Pharmacology
ePoster Station 4

12:05

#110 Assessment of male and female prevalence of overactive bladder (OAB) in Madrid (Spain) using a self-administered screening questionnaire: abbreviated version Overactive Bladder Awareness Tool OAB-V3.

Presenter: Javier C Angulo

Angulo J C¹, Calderín M D P², Fernández Y³, González M⁴, Gómez E⁵, Herreros M B⁶, Zapatero M⁷, Dorado J F⁸, Peñasco P⁹
1. Universidad Europea de Madrid. Hospital Universitario de Getafe, Getafe (Madrid), Spain, 2. Centro de Salud Ciudades, Getafe (Madrid), Spain, 3. Centro de Salud El Greco, Getafe (Madrid), Spain, 4. Centro de Salud de Pinto, Pinto (Madrid), Spain, 5. Centro de Salud Getafe Norte, Getafe (Madrid), Spain, 6. Centro de Salud Parque Europa, Getafe (Madrid), Spain, 7. Centro de Salud Juan de la Cierva, Getafe (Madrid), Spain, 8. Pertica S.L., Madrid, Spain, 9. Centro de Salud Sector III
Outcomes Research Methods, Overactive Bladder, Quality of Life (QoL), Questionnaire, Urgency/Frequency
ePoster Station 5

12:55

#111 Evaluation of treatment efficacy of mirabegron for overactive bladder in patients previously failing anticholinergic therapy

Presenter: Jan Krhut

Krhut J¹, Zachoval R², Martan A³, Hanus T⁴, Horcicka L⁵, Svabik K³, Halaska M⁶
1. Dept.of Urology, University Hospital, Ostrava, Czech Republic, 2. Dept. of Urology, Thomayer Hospital, Prague, Czech Republic, 3. Dept. of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and Faculty Hospital, Prague, Czech Republic, 4. Dept. of Urology, 1st Faculty of Medicine, Charles University and Faculty Hospital, Prague, Czech Republic, 5. GONA, Urogynecological office, Prague, Czech Republic, 6. Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
Overactive Bladder, Conservative Treatment, Voiding Diary, Quality of Life (QoL)
ePoster Station 4

12:10

#112 Comprehensive Bladder Assessment Tool: Instrument Development

Presenter: Christopher Chapple

Chapple C¹, Kelleher C², Evans C³, Kopp Z³, Johnson N³, Hakimi Z⁴, Siddiqui E⁴
1. University of Sheffield, 2. Guy's and St. Thomas Hospital, 3. Endpoint Outcomes, 4. Astellas
Overactive Bladder, Questionnaire, Outcomes Research Methods
ePoster Station 5

12:15

#113 Are male and female OAB different from a clinical perspective? Results from an observational study performed in Madrid (Spain).

Presenter: Javier C Angulo

Angulo J C¹, Calderín M D P², Fernández Y³, González M⁴, Gómez E⁵, Herreros M B⁶, Zapatero M⁷, Dorado J F⁸, Peñasco P⁹
1. Universidad Europea de Madrid. Hospital Universitario de Getafe, 2. Centro de Salud Ciudades, Getafe (Madrid), Spain, 3. Centro de Salud El Greco, Getafe (Madrid), Spain, 4. Centro de Salud de Pinto, Pinto (Madrid), Spain, 5. Centro de Salud Getafe Norte, Getafe (Madrid), Spain, 6. Centro de Salud Parque Europa, Getafe (Madrid), Spain, 7. Centro de Salud Juan de la Cierva, Getafe (Madrid), Spain, 8. Pertica S.L., Madrid, Spain, 9. Centro de Salud Sector III
Outcomes Research Methods, Overactive Bladder, Quality of Life (QoL), Questionnaire, Urgency/Frequency
ePoster Station 5

12:20

#114 Dry mouth of OAB patients treated with mirabegron and antimuscarnics

Presenter: Hirofumi Sakamoto

Sakamoto H¹, Asakura H¹, Hayashi T², Hanashima F², Nakahira Y², Yanaihara H²
1. Saitma Medical School, 2. Saitama Medical School
Pharmacology, Overactive Bladder, Conservative Treatment
ePoster Station 5

12:25

#115 Is there a Difference in the Tolerability of Overactive Bladder Medications?

Presenter: David Staskin

Staskin D¹, Herschorn S², Walsh T³, Bradt P³, Schermer C³, Schermer C³
1. Tufts University School of Medicine, 2. Sunnybrook Health Sciences Centre, 3. Astellas
Clinical Trial, Pharmacology, Questionnaire
ePoster Station 5

12:30

#116 A comparison study of overactive bladder (OAB) screening tools validated in Spanish (B-SAQ, OAB-V8 and OAB-V3) to address the diagnosis of OAB in clinical practice in Madrid (Spain).

Presenter: Javier C Angulo

Angulo J C¹, Calderín M D P², Fernández Y³, González M⁴, Gómez E⁵, Herreros M B⁶, Zapatero M⁷, Dorado J F⁸, Peñasco P⁹
1. Universidad Europea de Madrid. Hospital Universitario de Getafe. Getafe (Madrid), Spain, 2. Centro de Salud Ciudades, Getafe (Madrid), Spain, 3. Centro de Salud El Greco, Getafe (Madrid), Spain, 4. Centro de Salud de Pinto, Pinto (Madrid), Spain, 5. Centro de Salud Getafe Norte, Getafe (Madrid), Spain, 6. Centro de Salud Parque Europa, Getafe (Madrid), Spain, 7. Centro de Salud Juan de la Cierva, Getafe (Madrid), Spain, 8. Pertica S.L., Madrid, Spain, 9. Centro de Salud Sector III
Outcomes Research Methods, Overactive Bladder, Quality of Life (QoL), Questionnaire, Urgency/Frequency
ePoster Station 5

12:35

#117 Factors associated with the incidence of adverse drug reactions (ADRs) in patients with overactive bladder (OAB) treated with mirabegron: a Japanese post-marketing study

Presenter: Daisuke Kato

Kato D¹, Nozawa Y¹, Tabuchi H¹, Kuroishi K¹
1. Astellas Pharma Inc
Overactive Bladder, Prospective Study, Urgency/Frequency
ePoster Station 5

12:40

#118 Real-world cardiovascular assessment of mirabegron treatment in patients with overactive bladder and concomitant cardiovascular disease: results of a Japanese post-marketing study

Presenter: Daisuke Kato

Kato D¹, Katoh T², Kuwamoto K¹, Kuroishi K¹
1. Astellas Pharma Inc, 2. Cardiovascular Centre, International University of Health and Welfare, Mita Hospital, Tokyo, Japan
Overactive Bladder, Prospective Study, Urgency/Frequency
ePoster Station 5

12:45

#119 Risk Factors for UTI following bladder OnabotulinumtoxinA injections for refractory overactive bladder

Presenter: Arun Sahai

Evans Z¹, Van Hemelrijck M¹, Eldred-Evans D¹, Seth J¹, Malde S¹, Watkins J¹, Dasgupta P¹, Sahai A¹
1. Guy's Hospital and King's College London
Detrusor Overactivity, Incontinence, Infection, Urinary Tract
ePoster Station 5

12:50

#120 Parallel study of molecular changes in the prostate and bladder of men with benign prostate enlargement (BPE) and overactive bladder (OAB) symptoms and in comparison with controls

Presenter: Apostolos Apostolidis

Vardouli L¹, Markopoulou S¹, Sakalis V², Sfiggas V², Salpiggidis G², Mytilekas K³, Papathanasiou A², Ioannidis E³, Apostolidis A³
1. Department of Pharmacology, Aristotle University of Thessaloniki, Greece, 2. Department of Urology, Ippokration Hospital, Thessaloniki, Greece, 3. 2nd Department of Urology, Aristotle University of Thessaloniki, Greece
Benign Prostatic Hyperplasia (BPH), Molecular Biology, Overactive Bladder, Pathophysiology
ePoster Station 5

12:55

#121 PREDICTORS OF URGENCY IMPROVEMENT AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

Presenter: Dong Hwan Lee

Kim J C¹, Cho J J¹, Choi J B², Kim H W¹, Lee D H¹, Cho Y H¹
1. Dept. of Urology, The Catholic University of Korea, 2. Dept. of Urology, Ajou University
Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Urgency/Frequency
ePoster Station 5

12:05

#122 MICRORNAS AS POTENTIAL BIOMARKERS TO PREDICT RISK OF URINARY RETENTION FOLLOWING INTRADETRUSOR ONABOTULINUMTOXIN-A INJECTION

Presenter: Christopher Chermansky

Chermansky C¹, Kadow B¹, Kashyap M¹, Tyagi P¹
1. Dept of Urology - University of Pittsburgh
Urgency Urinary Incontinence, Basic Science, Overactive Bladder, Female, Pharmacology
ePoster Station 6

12:10

#123 Ovary hormone deficiency exacerbated high fat and high sugar diet - induced overactive bladder in a rat model

Presenter: Mei-Yu Jang

Jang M¹, Chuang S², Juan Y³, Lin K⁴, Chen S¹, Long C Y⁴
1. Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan;, 2. Kaohsiung Medical University, 3. Kaohsiung Medical University, Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan;, 4. Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Detrusor Overactivity, Animal Study, Basic Science
ePoster Station 6

12:15

#124 Therapeutic efficacy and patient satisfaction of mirabegron shifting from stable antimuscarinics therapy in patients with overactive bladder syndrome – analysis of predictive factors

Presenter: Chun-Hou Liao

Liao C¹, Jiang Y², Ong H², Tseng H², Kuo H²
1. Department of Urology, Cardinal Tien Hospital and School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Pharmacology, Urgency Urinary Incontinence, Incontinence
ePoster Station 6

12:20

#125 Pelvic Floor Surgery with Mesh (Elevate anterior/apical and posterior/apical) can cure symptoms of urinary frequency, urgency, urgency incontinence and nocturia over long time

Presenter: Bernhard Liedl

Liedl B¹, Lukban J², Stanford E³, Yassouridis A¹, Sutherland S E⁴
1. Pelvic Floor Centre of Munich, Germany, 2. Eastern Virginia Medical School, Norfolk, USA, 3. Doctor`s Medical Centre, Modesto, USA, 4. Female Urology, University Seattle, USA
Overactive Bladder, Prospective Study, Pelvic Floor, Grafts: Synthetic, Female
ePoster Station 6

12:25

#126 COMPARISON OF THE EFFICACY, TOLERABILITY AND SAFETY OF PROPIVERINE FOR THE TREATMENT OF OAB IN YOUNGER VS OLDER PATIENTS (</≥ 65 YEARS): A POST-HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND STUDY

Presenter: Elke Hessdoerfer

Hessdoerfer E¹, Juenemann K², Murgas S³, Oelke M⁴
1. Bladder Center Westend Berlin, Germany, 2. Department of Urology and Pediatric Urology, University of Schleswig Holstein, Campus Kiel, Germany, 3. APOGEPHA Arzneimittel GmbH, Dresden, Germany, 4. Department of Urology and Urological Oncology, Hannover Medical School, Germany
Overactive Bladder, Pharmacology, Urgency Urinary Incontinence, Clinical Trial
ePoster Station 6

12:30

#127 Contributing factors to failure of improvement of subjective symptoms after mirabegron administration in female patients with an overactive bladder

Presenter: Yoshihisa Matsukawa

Matsukawa Y¹, Funahashi Y¹, Majima T¹, Matsuo K¹, Fujita T¹, Yamamoto T¹, Gotoh M¹
1. Department of Urology, Nagoya University Graduate School of Medicine, Japan
Detrusor Overactivity, Overactive Bladder, Pharmacology, Female
ePoster Station 6

12:35

#128 Cytotoxicity of artificial urine in the development of a biodegradable mPEG carrier polymer for intravesical application

Presenter: Joachim Grosse

Arndt P¹, Neuss S¹, Huppertz N², Dittrich B³, Kossmann L¹, Kaltbeitzel D¹, Schwantes U⁴, Grosse J¹
1. RWTH Aachen University, 2. University Hospital Bonn, 3. DWI – Leibniz-Institute for Interactive Materials e.V, 4. Dr. R. Pfleger GmbH
Basic Science, Detrusor Overactivity, New Devices, Overactive Bladder, Pre-Clinical testing
ePoster Station 6

12:40

#129 Chronic administration of corticosterone may induce detrusor overactivity symptoms.

Presenter: Tomasz Rechberger

Wróbel A¹, Rechberger E¹, Miotla P¹, Romanek-Piva K¹, Adamiak-Godlewska A¹, Rechberger T¹
1. 2nd Department of Gynecology, Medical University of Lublin, Lublin, Poland
Animal Study, Overactive Bladder, Pathophysiology, Pharmacology, Basic Science
ePoster Station 6

12:45

#130 Evaluation of anxiety in older women treated for Overactive Bladder: posterior tibial electrical sensory stimulation Versus motor stimulation

Presenter: Aline Alves

Jacomo R¹, Alves A², Garcia P², Bontempo A², Botelho T², Rett M³, Bortolazzo A², Malschik D², de Menezes R², Amatuzzi F², de Sousa J²
1. University of Brasília, 2. University of Brasilia, 3. University of Sergipe
Overactive Bladder, Rehabilitation, Gerontology
ePoster Station 6

12:50

#131 Intravesical electrical stimulation treatment for overactive bladder syndrome: a pilot study

Presenter: Jeffrey Hardesty

Shen J¹, Yune J J¹, Hardesty J², Kim J³, Siddighi S²
1. Department of Urology, Loma Linda University Medical Center, 2. Female Pelvic Medicine and Reconstructive Surgery, Department of Gynecology and Obstetrics, Loma Linda University Medical Center, 3. School of Public Health, Loma Linda University
Overactive Bladder, Detrusor Overactivity, Incontinence, Female
ePoster Station 6

12:55

#132 EFFECT OF CONSTIPATION TREATMENT ON WOMEN WHO HAVE OVER ACTIVE BLADDER AND CONSTIPATION

Presenter: Ferhat Ates

Yilmaz O¹, Ates F¹, Aktas Z¹, Soydan H¹, Karademir A K¹
1. Gulhane Militarian Medical Academy, Haydarpasa Training Hospital, Department of Urology, Istanbul
Bowel Evacuation Dysfunction, Detrusor Overactivity, Constipation, Overactive Bladder
ePoster Station 6

12:05

#133 Investigation of availability of anti-cholinergic drug in female overactive bladder patients with insufficient effect of β3 receptor agonist -Switching study from mirabegron to solifenacin- WATCH (Woman Availability Trial by CHanging from mirabegron to solifenacin) Study

Presenter: Keiji Nakashima

Nakashima K¹
1. Takayama Hospital
Female, Overactive Bladder, Prospective Study, Questionnaire, Urgency Urinary Incontinence
ePoster Station 7

12:10

#134 STUDY OF THE EFFECT OF PATIENT POSITION ON THE MEASUREMENT OF VALSALVA LEAK POINT PRESSURE IN FEMALE STRESS URINARY INCONTINENCE

Presenter: Mostafa Elmissiry

Elmissiry M¹, Taher E¹, Ali G¹, Aboegila A¹
1. Alexandria University
Female, Stress Urinary Incontinence, Urodynamics Techniques
ePoster Station 7

12:15

#135 SPHINCTER RETROGRADE OPENING PRESSURE (PARE). A NEW TEST TO ASSESS URETHRAL SPHINCTER COMPETENCE AFTER RADICAL PROSTATECTOMY. DATA FROM PARE PROJECT

Presenter: Roberto Martinez-Garcia

Martinez-Garcia R¹, Valls-González L², Morales-Solchaga G³, Alonso-Gracia N², Martínez-Cuenca E⁴, Arlandis-Guzmán S⁴, Bonillo-García M Á⁴
1. Clinic University Hospital of Valencia (Spain). University of Valencia. Cluvaluf team, 2. Clinic University Hospital of Valencia (Spain). Cluvaluf team, 3. La Ribera Hospital of Alzira; Valencia (Spain). Cluvaluf team, 4. UP La Fe Hospital of Valencia (Spain). Cluvaluf team
Male, Incontinence, Urodynamics Techniques, Prospective Study
ePoster Station 7

12:20

#136 Videourodynamic studies of women with voiding dysfunction

Presenter: Sheng-Mou Hsiao

Hsiao S¹, Ong H², Wu S², Kuo H²
1. Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Voiding Dysfunction , Urodynamics Techniques, Pathophysiology
ePoster Station 7

12:25

#137 The Effects Of Prior Fluid Intake On The Measurement Of Post Void Residual Urine

Presenter: Chin Heng Lu

Lu C H¹, Lin C², Lin A T², Chen K²
1. Taipei Veterans General Hospital, 2. 1.Department of Urology, Taipei Veterans General Hospital 2. Department of Urology, School of Medicine and 3.Shu-Tien Urological Science Research Center, National Yang-Ming University
Urodynamics Techniques, Physiology, Prospective Study
ePoster Station 7

12:10

#138 Effect of Age on Detrusor Muscle Reserve in adult males: A clinicl study

Presenter: Mohamed Hassouna

Hassouna M¹, Abouel-Fottouh A¹, Abdulmoula A², Shoukry M³
1. Faculty of Medicine-Alexandria University, Egypt, 2. tripoly, Libya, 3. Faculty of Medicine-Alexandria University,Egypt
Bladder Outlet Obstruction , Clinical Trial, Male, Urodynamics Techniques
ePoster Station 8

12:30

#139 The apparent diffusion coefficient (ADC) value of bladder smooth muscle predicts bladder dysfunction

Presenter: Hidenori Akaihata

Akaihata H¹, Haga N¹, Kushida N¹, Yanagida T¹, Ishibashi K¹, Aikawa K¹, Kojima Y¹
1. Fukushima medical university
Detrusor Overactivity, Urodynamics Techniques, Urgency/Frequency
ePoster Station 7

12:35

#140 The accuracy of urodynamics pressure measurement with water-filled systems

Presenter: Andrew Gammie

Gammie A¹
1. Bristol Urological Institute
Urodynamics Techniques, Urodynamics Equipment, Terminology
ePoster Station 7

12:45

#141 Female LUTS related to Urethral Instability Evaluated by Synchronous Urethrocystometry

Presenter: Jian Guo Wen

Wen J G¹, Zhai R Q², Lu Y T²
1. First Affiliated Hospital of Zhengzhou University,, 2. First Affiliated Hospital of Zhengzhou University
Detrusor Overactivity, Urodynamics Techniques, Female, Stress Urinary Incontinence, Urgency/Frequency
ePoster Station 7

12:50

#142 Characteristics of voiding dysfunction in renal transplant recipients.

Presenter: Yang Min-Hsin

Min-Hsin Y¹, Yu-Lin K¹, Sun-Lang C¹, Shao-Chuan W¹, Wen-Jung C¹, Zuou-Yi S²
1. Division of Urology, Chung Shan Medical University Hospital, Taichung, Taiwan, 2. Division of Urology, Chung Shan Medical University Hospital, Taichung, Taiwan Edit
Voiding Dysfunction , Female, Male, Urgency/Frequency, Urodynamics Techniques
ePoster Station 7

12:55

#143 The change of bladder shape during filling phase - DO bladder during filling becomes vertical like voiding bladder

Presenter: Chiharu Shibata

Shibata C¹, Sakakibara R², Ishii T³, Kaga K⁴, Uchiyama T⁴, Awa Y⁵, Oikawa S⁶, Igarashi T³, Yamanishi T⁴
1. Continence Center / Clinical laboratory center , Dokkyo Medical University Hospital, 2. Neurology, Internal Medicine, Sakura Medical Center, Toho University, 3. Center for Frontier Medical Engineering, Chiba University, 4. Continence Center, Dokkyo Medical University Hospital, 5. Funabashi Clinic, 6. Clinical laboratory center, Dokkyo Medical University Hospital
Detrusor Overactivity, Female, Male, Urodynamics Techniques
ePoster Station 7

12:05

#144 Mathematical Modelling Analysis of Male Urine Flow Traces

Presenter: Rui Li

Li R¹, Gammie A², Zhu Q¹, Nibouche M¹
1. University of the West of England, 2. Bristol Urological Institute
Bladder Outlet Obstruction , Mathematical or statistical modelling, Underactive Bladder, Urodynamics Techniques
ePoster Station 8

12:15

#145 Estimation of Detrusor Muscle Reserve using a novel prototype test of simulated outflow resistance in adult males.

Presenter: Mohamed Hassouna

Hassouna M¹, Abouel-Fottouh A¹, Abdulmoula A², Shoukry M¹
1. Faculty of Medicine-Alexandria University, Egypt, 2. Tripoli-Libya
Bladder Outlet Obstruction , Male, Urodynamics Techniques
ePoster Station 8

12:20

#146 Grade of Normalcy Improves Inter-raters’ agreement in the interpretation of uroflowmetry

Presenter: Chih-Chin Yu

Yang S S¹, Yu C¹, Chang S¹
1. 1. Division of Urology, Taipei Tzu Chi Hospital, New Taipei, 2.School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan.
Urodynamics Techniques, Imaging, Terminology
ePoster Station 8

12:25

#147 Evaluation of intra-individual test-re-test variability of uroflowmetry in healthy women and women with lower urinary tract symptoms.

Presenter: Marcel Gärtner

Gärtner M¹, Krhut J², Lunacek L², Mika D², Szabova O¹, Vasek P¹, Zvarova K³, Zvara P⁴
1. Department of Gynaecology and Obstetrics, University Hospital, Ostrava, Czech Republic, 2. Department of Urology, University Hospital, Ostrava, Czech Republic, Department of Surgical Studies, Ostrava University, Ostrava, Czech Republic, 3. Department of Physiology, Slovak Medical University, Bratislava, Slovak Republic, 4. Department of Surgery, Department of Urology and Biomedical Laboratory, University of Southern Denmark, Odense, Denmark, Department of Surgical Studies, Ostrava University, Ostrava, Czech Republic
Urodynamics Techniques, Female, Stress Urinary Incontinence, Overactive Bladder, Mixed Urinary Incontinence
ePoster Station 8

12:40

#148 Symptoms and Signs to distinguish Detrusor Underactivity from Mixed Detrusor Underactivity and Bladder Outlet Obstruction in Male Patients

Presenter: Andrew Gammie

Gammie A¹, Yoshida S², Steup A², Kaper M³, Dorrepaal C³, Kos T², Abrams P¹
1. Bristol Urological Institute, 2. Astellas Pharma Europe B.V., 3. Astellas Pharma Europe B.V
Bladder Outlet Obstruction , Male, Underactive Bladder, Urodynamics Techniques
ePoster Station 7

12:30

#149 Free uroflowmetry versus pressure-flow study in the diagnosis of an overactive bladder syndrome in female patients.

Presenter: Konrad Futyma

Futyma K¹, Nowakowski L¹, Zietek A¹, Bogusiewicz M¹, Rechberger T¹
1. II Chair and Department of Gynaecology Medical University of Lublin
Urodynamics Techniques, Overactive Bladder, Mixed Urinary Incontinence, Female
ePoster Station 8

12:35

#150 Factors determining the amount of residual urine in men with bladder outlet obstruction: Could it be a predictor for bladder contractility?

Presenter: Mostafa Elmissiry

Elmissiry M¹, Ali A¹, Abulfotooh A¹, Moussa A¹, Ali G¹
1. Alexandria University
Bladder Outlet Obstruction , Male, Urodynamics Techniques
ePoster Station 8

12:40

#151 Risk factors of low detrusor function in benign prostate hyperplasia patients: Determining a prognostic factor to predict the optimam timing for surgical treatment.

Presenter: Tetsuichi Saito

Saito T¹, Suzuki T¹, Domen T¹, Ishikawa M¹, Nagai T¹, Hirakata S¹, Minagawa T¹, Ogawa T¹, Ichino M², Ishizuka O¹
1. Shinshu University School of Medicine, 2. Nagano Children`s Hospital
Benign Prostatic Hyperplasia (BPH), Detrusor Hypocontractility, Surgery, Urodynamics Techniques
ePoster Station 8

12:55

#152 Effect of preoperative urodynamic detrusor underactivity on transurethral surgery for benign prostatic hyperplasia: systematic review and meta-analysis

Presenter: Ho Joon Jeon

Kim M¹, Jeon H J², Jeong C W², Oh S²
1. Department of Urology, Asan Medical Center, Seoul, Korea, 2. Department of Urology, Seoul National University Hospital, Seoul, Korea
Benign Prostatic Hyperplasia (BPH), Male, Surgery, Underactive Bladder
ePoster Station 8

12:45

#153 The 3D-ultrasound oriented adjustment for sphincteric urethra prior to Doppler ultrasound videourodynamics -Repeatability of velocity-flow parameters.

Presenter: Hideo Ozawa

Ozawa H¹, Yakushiji H¹, Fukuda K², Yabuki T³, Nagai A⁴, Kumon H⁵
1. Kawasaki Hospital, Kawasaki Medical School, 2. Hitachi-Aloka Medical Co., 3. Coatec Inc., 4. Kawasaki Medical School, 5. Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Bladder Outlet Obstruction , Imaging, Male, Urodynamics Equipment, Benign Prostatic Hyperplasia (BPH)
ePoster Station 8

12:50

#154 Symptomatic Urinary Tract Infections' Rate Post-Urodynamic Studies and Risk Factors

Presenter: Ariel Levy

Levy A¹, Vainrib M¹
1. Meir Medical Center
Prevention, Urodynamics Techniques, Infection, Urinary Tract, Retrospective Study
ePoster Station 8

Open Discussion ePosters

Scientific Open Discussion Session S7

Session Schedule

Comments

Chat